Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Hietanen, A. Aro, K. Holli, P. Absetz (2000)
Information and communication in the context of a clinical trial.European journal of cancer, 36 16
N. Aaronson, E. Visser-Pol, G. Leenhouts, M. Muller, A. schot, F. Dam, R. Keus, C. Koning, W. Huinink, J. Dongen, R. Dubbelman (1996)
Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14 3
C. Daugherty (2004)
Ethical Issues in the Development of New AgentsInvestigational New Drugs, 17
K. Schutta, C. Burnett (2000)
Factors that influence a patient's decision to participate in a phase I cancer clinical trial.Oncology nursing forum, 27 9
M. Schaeffer, David Krantz, A. Wichman, H. Masur, E. Reed, J. Vinicky (1996)
The impact of disease severity on the informed consent process in clinical research.The American journal of medicine, 100 3
(1998)
Taking Part in Clinical Trials: What Cancer Patients Need To Know [booklet]
B. Rimer, Bernard Glassman (1999)
Is there a use for tailored print communications in cancer risk communication?Journal of the National Cancer Institute. Monographs, 25
David Farrell, B. Rimer, Laura Olevitch, L. Brennan, M. Kreuter (1999)
Tailoring Health Messages: Customizing Communication With Computer Technology
A. November (2003)
American Society of Clinical Oncology policy statement: oversight of clinical research.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 12
M Holmes-Rovner, J Kroll, N Schmitt (1996)
Patient satisfaction with health care decisions: The Satisfaction with Decision ScaleMedical Decis Making, 16
P. Ellis (2000)
Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature.Annals of oncology : official journal of the European Society for Medical Oncology, 11 8
S. Joffe, E. Cook, P. Cleary, Jeffrey Clark, J. Weeks (2001)
Quality of informed consent: a new measure of understanding among research subjects.Journal of the National Cancer Institute, 93 2
K. Cox (2002)
Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials.Patient education and counseling, 46 1
M. McCabe (1999)
The ethical foundation of informed consent in clinical research.Seminars in oncology nursing, 15 2
G. Huizinga, D. Sleijfer, H. Wiel, W. Graaf (1999)
Decision-making process in patients before entering phase III cancer clinical trials: a pilot study.Cancer nursing, 22 2
M. Holmes-Rovner, J. Kroll, N. Schmitt, D. Rovner, M. Breer, M. Rothert, G. Padonu, G. Talarczyk (1996)
Patient Satisfaction with Health Care DecisionsMedical Decision Making, 16
D. Stacey, F. Légaré, N. Col, Carol Bennett, M. Barry, K. Eden, M. Holmes-Rovner, H. Llewellyn-Thomas, A. Lyddiatt, R. Thomson, L. Trevena, Julie Wu (2003)
Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews, 2
C. Coyne, R. Xu, P. Raich, K. Plomer, M. Dignan, L. Wenzel, D. Fairclough, T. Habermann, Linda Schnell, S. Quella, D. Cella (2003)
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 5
Sarah Edwards, R. Lilford, Jenny Hewison (1998)
The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionalsBMJ, 317
S. Joffe, S. Joffe, E. Cook, P. Cleary, Jeffrey Clark, J. Weeks, J. Weeks (2001)
Quality of informed consent in cancer clinical trials: a cross-sectional surveyThe Lancet, 358
Katie Featherston, J. Donovan (1998)
Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trialBMJ, 317
Background. Accepted practices of informed consent often result in suboptimal patient understanding of research studies.Methods. This pilot study aimed to assess trial-specific tailored materials, compared to a widely used generic booklet about clinical trials, randomly assigned to 118 candidates for cancer clinical trials. Study outcomes were: satisfaction with decision-making; satisfaction with materials; and subjective understanding of the clinical trial.Results. There were no major differences between groups. Participants rated tailored materials higher as a useful reference.Conclusions. Trial-specific materials hold utility for reference during clinical trials. Studies of informed consent are feasible, although important factors limit research.
Journal of Cancer Education – Springer Journals
Published: Nov 16, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.